SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 167 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $174,000 | -76.6% | 16,586 | -75.5% | 0.01% | -78.3% |
| Q1 2017 | $745,000 | -18.9% | 67,771 | -0.1% | 0.02% | -4.2% |
| Q4 2016 | $919,000 | +366.5% | 67,811 | +276.7% | 0.02% | +500.0% |
| Q2 2016 | $197,000 | -58.9% | 18,000 | -58.9% | 0.00% | -66.7% |
| Q1 2016 | $479,000 | -10.6% | 43,846 | +41.4% | 0.01% | -20.0% |
| Q4 2015 | $536,000 | -42.5% | 31,008 | -33.9% | 0.02% | -53.1% |
| Q3 2015 | $932,000 | +272.8% | 46,925 | +208.5% | 0.03% | +357.1% |
| Q2 2015 | $250,000 | +21.4% | 15,209 | +15.1% | 0.01% | 0.0% |
| Q1 2015 | $206,000 | +15.1% | 13,209 | +5.2% | 0.01% | +16.7% |
| Q4 2014 | $179,000 | +115.7% | 12,561 | -1.6% | 0.01% | +100.0% |
| Q3 2014 | $83,000 | – | 12,761 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 925,214 | $8,697,000 | 1.43% |
| Penbrook Management LLC | 69,725 | $655,000 | 0.64% |
| Granahan Investment Management | 1,171,399 | $11,011,000 | 0.28% |
| Visium Asset Management, LP | 1,500,000 | $14,100,000 | 0.28% |
| ALGERT GLOBAL LLC | 99,846 | $939,000 | 0.25% |
| OBERWEIS ASSET MANAGEMENT INC/ | 53,000 | $498,000 | 0.12% |
| TFS CAPITAL LLC | 149,004 | $1,401,000 | 0.07% |
| CADENCE CAPITAL MANAGEMENT LLC | 144,305 | $1,356,000 | 0.05% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 20,567 | $194,000 | 0.04% |
| SHEPHERD KAPLAN KROCHUK, LLC | 31,878 | $300,000 | 0.04% |